Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
643.10
-21.8 (-3.28%)
BSENSE

Nov 20

BSE+NSE Vol: 3.88 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
313.37
285.58
256.99
218.25
244.40
207.47
197.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
313.37
285.58
256.99
218.25
244.40
207.47
197.99
Raw Material Cost
135.82
94.64
111.26
86.22
95.37
93.41
76.61
Purchase of Finished goods
11.72
15.10
18.21
20.20
2.26
20.57
13.53
(Increase) / Decrease In Stocks
-28.08
4.71
-16.01
-4.76
20.42
-22.10
9.29
Employee Cost
44.99
43.05
36.14
35.94
33.35
31.00
28.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
68.33
51.68
62.95
45.86
49.52
43.25
49.23
Total Expenditure (Excl Depreciation)
232.78
209.17
212.55
183.46
200.92
166.14
176.90
Operating Profit (PBDIT) excl Other Income
80.59
76.41
44.44
34.79
43.48
41.33
21.09
Other Income
8.30
9.60
11.16
18.46
8.46
35.45
12.07
Operating Profit (PBDIT)
88.89
86.01
55.60
53.25
51.94
76.78
33.16
Interest
3.30
0.58
2.01
1.49
3.04
5.47
1.68
Exceptional Items
0.00
0.00
0.03
-2.51
0.00
0.00
0.00
Gross Profit (PBDT)
85.59
85.43
53.62
49.25
48.90
71.31
31.48
Depreciation
10.50
9.94
8.67
8.35
8.26
8.20
8.04
Profit Before Tax
75.10
75.48
44.95
40.90
40.63
63.11
23.44
Tax
21.76
24.11
7.95
16.12
12.04
18.75
6.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
53.34
51.37
37.00
24.78
28.59
44.36
16.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
53.34
51.37
37.00
24.78
28.59
44.36
16.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.09
1.27
1.42
1.51
1.34
1.32
1.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.25
50.10
35.58
23.27
27.25
43.04
15.54
Equity Capital
10.64
10.61
10.58
10.58
10.56
10.55
10.54
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.91
4.72
3.36
2.2
2.58
4.08
1.47
Diluted Earnings per share
4.81
4.65
3.28
2.14
2.54
4.04
1.46
Operating Profit Margin (Excl OI)
25.72%
26.76%
17.29%
15.94%
17.79%
19.92%
10.65%
Gross Profit Margin
27.31%
29.91%
20.86%
22.57%
20.01%
34.37%
15.9%
PAT Margin
17.02%
17.99%
14.4%
11.35%
11.7%
21.38%
8.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 28.22% vs 12.27% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 91.74% vs 12.32% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 85.35% vs 4.82% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 8.55% vs -20.63% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of Bliss GVS Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
313.37
535.90
-222.53
-41.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
313.37
535.90
-222.53
-41.52%
Raw Material Cost
135.82
75.70
60.12
79.42%
Purchase of Finished goods
11.72
84.10
-72.38
-86.06%
(Increase) / Decrease In Stocks
-28.08
80.70
-108.78
-134.80%
Employee Cost
44.99
53.80
-8.81
-16.38%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
68.33
69.70
-1.37
-1.97%
Total Expenditure (Excl Depreciation)
232.78
364.00
-131.22
-36.05%
Operating Profit (PBDIT) excl Other Income
80.59
171.90
-91.31
-53.12%
Other Income
8.30
3.30
5.00
151.52%
Operating Profit (PBDIT)
88.89
175.20
-86.31
-49.26%
Interest
3.30
0.30
3.00
1,000.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
85.59
174.90
-89.31
-51.06%
Depreciation
10.50
9.60
0.90
9.38%
Profit Before Tax
75.10
165.30
-90.20
-54.57%
Tax
21.76
45.80
-24.04
-52.49%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
53.34
119.50
-66.16
-55.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
53.34
119.50
-66.16
-55.36%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.09
0.00
1.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.25
119.50
-67.25
-56.28%
Equity Capital
10.64
23.00
-12.36
-53.74%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.91
51.96
-47.05
-90.55%
Diluted Earnings per share
4.81
51.89
-47.08
-90.73%
Operating Profit Margin (Excl OI)
25.72%
32.08%
0.00
-6.36%
Gross Profit Margin
27.31%
32.64%
0.00
-5.33%
PAT Margin
17.02%
22.30%
0.00
-5.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 313.37 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 9.73% vs 11.12% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 28.22% vs 12.27% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 52.25 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.29% vs 40.81% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 91.74% vs 12.32% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 80.59 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 5.47% vs 71.94% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 85.35% vs 4.82% in Sep 2025

Quarterly - Interest
Interest 3.30 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 468.97% vs -71.14% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.55% vs -20.63% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.72%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025